Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Vitamin D deficiency was similar in the fracture group (35%) and the non-fracture group (36%) whereas deficiencies of albumin (32% vs. 13%), vitamin C (71% vs. 39%) and vitamin B12 (38% vs. 18%) and elevated homocysteine levels (33% vs. 27%) were more prevalent in the fracture compared with the non-fracture group.

Source: 3.1. Patient Characteristics and Unadjusted Between-Group Comparisons. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This prospective cross-sectional case: control study included 108 consecutive patients who presented to the Royal Adelaide Hospital between April 2022 and February 2024 for treatment of (1) fragility hip fracture (n = 63, fracture group) and (2) hip osteoarthritis (n = 45, non-fracture group).

Source: Methods.

Patients were excluded if they had CKD, diabetes, primary or secondary hyperparathyroidism, inflammatory arthritis, inflammatory bowel disease or cancer; if they had elevated alkaline phosphatase (ALP) >110 U/L; or if they were taking medications known to affect bone metabolism, including glucocorticoids, antiresorptive agents or warfarin ().

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin K Status and Skeletal Fragility: Differential Associations of Osteocalcin Carboxylation States with Bone Strength, Geometry and Microarchitecture

Case-control study · Nutrients · 2026

Original publication title

Vitamin K Status and Skeletal Fragility: Differential Associations of Osteocalcin Carboxylation States with Bone Strength, Geometry and Microarchitecture

Deepti K. Sharma; Chloe Furst; Rebecca Bahnisch; Christopher Schultz; Manuela Rogers; Tim Cheok; Lucian B. Solomon; Stuart A. Callary; Boopalan Ramasamy

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background:

The contribution of specific nutritional biomarkers to skeletal fragility remains poorly understood, in part because most studies include participants with metabolic conditions that obscure nutrient-specific effects. We aimed to examine incremental contribution of six pathway-specific nutritional biomarkers.

Methods:

In a prospective cross-sectional case: control design, 108 patients undergoing arthroplasty were enrolled (hip-fracture, n = 63; non-fracture, n = 45), and bone biopsies and blood specimens were collected intraoperatively. Circulating biomarkers reflecting vitamin K, one-carbon metabolism, antioxidant nutrients (vitamins E and C), protein and zinc status were measured. Bone outcomes included remodelling markers, trabecular microarchitecture and bone strength. Hierarchical regression was used to quantify the incremental contribution of nutritional biomarkers beyond clinical covariates with a priori outcome selection.

Results:

Bone remodelling markers did not differ between groups after covariate adjustment, indicating that fractures in this cohort were characterised by deficits in bone strength and quality rather than elevated systemic remodelling activity. Among six nutritional pathways tested, only vitamin K-dependent biomarkers showed consistent independent associations with bone outcomes, suggesting a degree of pathway specificity. Critically, carboxylated (cOC), undercarboxylated (ucOC) and fully uncarboxylated (unOC) osteocalcin fractions showed differential associations reflecting their distinct biological roles: cOC was independently associated with greater bone strength (section modulus, femoral neck width and cortical shaft thickness; p < 0.05) and lower trabecular separation (Tb.Sp); ucOC was associated with higher Tb.Sp (p = 0.004); and unOC was positively associated with cortical bone instability (buckling ratio, p = 0.003) and explained 17% of the variance in the bone resorption marker (p < 0.001), consistent with a shift towards bone loss. Vitamin K2-7 was negatively associated with hip axis length (p = 0.021).

Conclusions:

These findings identify vitamin K-dependent carboxylation as a mechanistically specific and modifiable factor associated with skeletal fragility beyond bone mineral density, with distinct skeletal consequences across osteocalcin carboxylation states.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The contribution of specific nutritional biomarkers to skeletal fragility remains poorly understood, in part because most studies include participants with metabolic conditions that obscure nutrient-specific effects. We aimed to examine incremental contribution of six pathway-specific nutritional biomarkers.

Source: Background:

Abstract: Results

Bone remodelling markers did not differ between groups after covariate adjustment, indicating that fractures in this cohort were characterised by deficits in bone strength and quality rather than elevated systemic remodelling activity. Among six nutritional pathways tested, only vitamin K-dependent biomarkers showed consistent independent associations with bone outcomes, suggesting a degree of pathway specificity. Critically, carboxylated (cOC), undercarboxylated (ucOC) and fully uncarboxylated (unOC) osteocalcin fractions showed differential associations reflecting their distinct biological roles: cOC was independently associated with greater bone strength (section modulus, femoral neck width and cortical shaft thickness; p < 0.05) and lower trabecular separation (Tb.Sp); ucOC was associated with higher Tb.Sp (p = 0.004); and unOC was positively associated with cortical bone instability (buckling ratio, p = 0.003) and explained 17% of the variance in the bone resorption marker (p < 0.001), consistent with a shift towards bone loss. Vitamin K2-7 was negatively associated with hip axis length (p = 0.021).

Source: Results:

Abstract: Conclusions

These findings identify vitamin K-dependent carboxylation as a mechanistically specific and modifiable factor associated with skeletal fragility beyond bone mineral density, with distinct skeletal consequences across osteocalcin carboxylation states.

Source: Conclusions
Authors’ abstract

Background:

The contribution of specific nutritional biomarkers to skeletal fragility remains poorly understood, in part because most studies include participants with metabolic conditions that obscure nutrient-specific effects. We aimed to examine incremental contribution of six pathway-specific nutritional biomarkers.

Methods:

In a prospective cross-sectional case: control design, 108 patients undergoing arthroplasty were enrolled (hip-fracture, n = 63; non-fracture, n = 45), and bone biopsies and blood specimens were collected intraoperatively. Circulating biomarkers reflecting vitamin K, one-carbon metabolism, antioxidant nutrients (vitamins E and C), protein and zinc status were measured. Bone outcomes included remodelling markers, trabecular microarchitecture and bone strength. Hierarchical regression was used to quantify the incremental contribution of nutritional biomarkers beyond clinical covariates with a priori outcome selection.

Results:

Bone remodelling markers did not differ between groups after covariate adjustment, indicating that fractures in this cohort were characterised by deficits in bone strength and quality rather than elevated systemic remodelling activity. Among six nutritional pathways tested, only vitamin K-dependent biomarkers showed consistent independent associations with bone outcomes, suggesting a degree of pathway specificity. Critically, carboxylated (cOC), undercarboxylated (ucOC) and fully uncarboxylated (unOC) osteocalcin fractions showed differential associations reflecting their distinct biological roles: cOC was independently associated with greater bone strength (section modulus, femoral neck width and cortical shaft thickness; p < 0.05) and lower trabecular separation (Tb.Sp); ucOC was associated with higher Tb.Sp (p = 0.004); and unOC was positively associated with cortical bone instability (buckling ratio, p = 0.003) and explained 17% of the variance in the bone resorption marker (p < 0.001), consistent with a shift towards bone loss. Vitamin K2-7 was negatively associated with hip axis length (p = 0.021).

Conclusions:

These findings identify vitamin K-dependent carboxylation as a mechanistically specific and modifiable factor associated with skeletal fragility beyond bone mineral density, with distinct skeletal consequences across osteocalcin carboxylation states.

Publication and source details

Original title: Vitamin K Status and Skeletal Fragility: Differential Associations of Osteocalcin Carboxylation States with Bone Strength, Geometry and Microarchitecture

Deepti K. Sharma; Chloe Furst; Rebecca Bahnisch; Christopher Schultz; Manuela Rogers; Tim Cheok; Lucian B. Solomon; Stuart A. Callary; Boopalan Ramasamy

Nutrients · 2026

* Correspondence: deepti.sharma@adelaide.edu.au© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.Bone Health FoundationSynergia Life Science University of Adelaidehttps://ror.org/02w043707 The authors acknowledge seed funding received from the Bone Health Foundation; Synergia Life Sciences; and the Building Leader’s Grant from the Faculty of Health and Medical Sciences, The University of Adelaide.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:54:38.272751+00:00

DOI: 10.3390/nu18162663 · PMC13516068